Recognition of carbohydrates on glycosylated molecules typically requires multivalent interactions with receptors. Monovalent forms of terminal saccharides engaged by the receptor binding sites typically display weak affinities in the mM range and poor specificity. In contrast, multivalent forms of the same saccharides are bound with strong affinity (10 ؊7 -10 ؊9 M) and significantly greater specificity. Although multivalency can readily account for increased affinity, the molecular basis for enhanced specificity is not well understood. We have examined the specificity of the cysteine-rich domain of the mannose/GalNAc-4-SO 4 receptor using monovalent and multivalent forms of the trisaccharide GalNAc1,4GlcNAc1,2Man␣ (GGnM) sulfated at either the C4 (S4GGnM) or C3 ( We previously demonstrated that glycoproteins such as LH 1 and thyrotropin bearing N-linked oligosaccharides terminating with 1,4-linked GalNAc-4-SO 4 are recognized by a receptor located in hepatic endothelial cells, the Man/GalNAc-4-SO 4 receptor, and are rapidly removed from the circulation (1-4). Rapid clearance in conjunction with stimulated release from dense core storage granules in LH-producing cells located in the anterior lobe of the pituitary produce the episodic rise and fall in serum LH levels that is important for the expression of LH bioactivity in vivo. A novel feature of the Man/GalNAc-4-SO 4 receptor is its capacity to bind carbohydrate moieties terminating with Man and GalNAc-4-SO 4 at physically distinct domains that are not structurally related. The binding site for GalNAc-4-SO 4 is located in the cysteine-rich domain found at the N terminus of the Man/GalNAc-4-SO 4 receptor (5). The Cys-rich domain is a member of the -trefoil family of proteins that includes proteins such as acidic fibroblast growth factor. The binding site is a neutral pocket that accommodates the sulfate group, which accounts for the major interactions with the protein (6). Inhibition and modeling studies with monovalent ligands have indicated that the binding site in the Cys-rich domain can also accommodate saccharides with terminal Gal or GalNAc when the sulfate is located at C3 rather than C4 (6, 7).The latter observations were unexpected because we had reported that bovine serum albumin substituted with 6 -8 molecules of SO 4 -4-GalNAc1,4GlcNAc1,2Man␣ (S4GGnM-BSA) is removed from the circulation at a rate that is at least 12-fold greater than that seen for bovine serum albumin substituted with 6 -8 molecules of SO 4 -3-GalNAc1,4GlcNAc1,2Man␣ (S3GGnM-BSA). Furthermore, isolated hepatic endothelial cells do not bind and internalize S3GGnM-BSA, and the purified Man/GalNAc-4-SO 4 receptor does not display significant binding of S3GGnM-BSA in precipitation assays (2, 3). We have recently determined that the Man/GalNAc-4-SO 4 receptor must be dimeric and engage at least two terminal GalNAc-4-SO 4 moieties on separate oligosaccharides to mediate uptake by hepatic endothelial cells with a K d of 1.63 ϫ 10 Ϫ7 M (8). These observations raise the possibility th...